Ouster is paying $35 million along with 1.8 million shares.
The CardioMEMS HF System enables daily home monitoring and has been shown to reduce hospital admissions in high-risk patients with chronic heart failure.
The FDA has updated some information about the December recall of certain Abbott FreeStyle Libre 3 and 3 Plus glucose sensors ...
I Tested the ‘Thermometer of the Future,’ and I Think This Is Its Ideal User ...
220 Triathlon on MSN
Breath analysing masks, ventilation sensors and bargain power meters: sports tech that will change your life in 2026
These cutting-edge sensors could transform your training but don't all come cheap.
AZoSensors on MSN
Dynamic42 closes a critical gap in organ-on-chip research by embedding oxygen sensing
Dynamic42 GmbH, a German developer of advanced human organ-on-chip technologies, today announces the launch of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results